New research reveals for the first time the atomic structures of a key molecular receptor in the brain, which opens the door for developing medications that could block activation of these receptors to address a variety of conditions, ranging from pain to high blood pressure to early formation of blood clots.

Restoring tumor-specific immunity is a treatment strategy that works well in melanoma and lung cancer patients.

A new study led by nationally prominent stem cell scientist Markus Grompe, M.D., has determined the existence of at least four separate subtypes of human insulin producing beta cells that may be important in the understanding and treatment of ...

A first-of-its-kind controlled clinical trial found that a low-fat, plant-based diet significantly improved the health of people with multiple sclerosis by reducing both fatigue and weight. Those improvements go hand-in-hand with fighting some of the most debilitating effects of MS.

With $42 million in funding from the National Institutes of Health, scientists from Beth Israel Deaconess Medical Center (BIDMC) and Oregon Health &Science University (OHSU) will lead a five-year research initiative to advance efforts to cure and ...

Marc Freeman, Ph.D., a former Howard Hughes Medical Institute investigator and a fast-rising star in the field of biology, will direct the Oregon Health & Science University Vollum Institute. The institute is widely recognized as a center of ...

Scientists at Oregon Health & Science University’s Casey Eye Institute and Baylor College of Medicine’s Cullen Eye Institute published findings from a two-year Phase I clinical trial in the journal Ophthalmology, which showed that children had the ...

For the first time, scientists have confirmed the long-standing hypothesis that as people age, they accumulate gene mutations in their mitochondria -- cells' energy source. A team led by Shoukhrat Mitalipov, Ph.D., director of the Center for Embryonic ...